切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2019, Vol. 13 ›› Issue (04) : 272 -276. doi: 10.3877/cma.j.issn.1674-0785.2019.04.006

所属专题: 文献

临床研究

Turbo Hawk斑块旋切系统治疗下肢动脉硬化闭塞症的疗效评估
管圣1,(), 杨建平1, 唐加热克1, 戈小虎1   
  1. 1. 830001 乌鲁木齐,新疆维吾尔自治区人民医院血管外科
  • 收稿日期:2018-08-21 出版日期:2019-02-15
  • 通信作者: 管圣

Efficacy of Turbo Hawk atherectomy system in treatment of lower extremity arteriosclerosis obliterans

Sheng Guan1,(), Jianping Yang1, Jiareke Tang1, Xiaohu Ge1   

  1. 1. Department of Vascular Surgery, People′s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China
  • Received:2018-08-21 Published:2019-02-15
  • Corresponding author: Sheng Guan
  • About author:
    Corresponding author: Guan Sheng, Email:
引用本文:

管圣, 杨建平, 唐加热克, 戈小虎. Turbo Hawk斑块旋切系统治疗下肢动脉硬化闭塞症的疗效评估[J]. 中华临床医师杂志(电子版), 2019, 13(04): 272-276.

Sheng Guan, Jianping Yang, Jiareke Tang, Xiaohu Ge. Efficacy of Turbo Hawk atherectomy system in treatment of lower extremity arteriosclerosis obliterans[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(04): 272-276.

目的

探讨Turbo Hawk斑块旋切系统治疗股浅动脉硬化狭窄或闭塞患者的临床疗效及应用价值。

方法

本研究回顾分析新疆维吾尔自治区人民医院2016年1月至2017年12月经下肢动脉成像确诊股浅动脉硬化闭塞或狭窄,且使用Turbo Hawk斑块旋切系统治疗的60例患者的临床资料,评估术后患者临床症状改善程度、管腔通畅度及血流动力学改善情况。采用t检验比较术前术后患者股浅动脉病变处管腔狭窄程度和踝肱指数(ABI)的差异。

结果

60病例符合Rutherford分类法3~6级的患者,术后临床症状明显改善的占46.67%(28/60),术后临床症状中度改善占53.33%(32/60)。术后数字减影心血管造影术(DSA)示管腔狭窄程度较术前明显下降[(0.26±0.05)分vs (0.90±0.08)分],差异具有统计学意义(t=2.847,P=0.015),术后ABI较术前明显升高(0.85±0.11 vs 0.25±0.13),差异具有统计学意义(t=1.546,P=0.023)。

结论

Turbo Hawk斑块切除术可以清除股浅动脉硬化闭塞斑块,开通狭窄或闭塞的动脉管腔,改善患者临床症状,是一种有效地腔内减容方案。

Objective

To assess the clinical efficacy and application value of the Turbo Hawk atherectomy system in treating patients with superficial femoral artery stenosis or occlusion.

Methods

This study retrospectively analyzed the clinical data of 60 patients with superficial femoral arteriosclerosis occlusion or stenosis diagnosed by lower extremity artery imaging and treated with the TurboHawk plaque circumcision system at Xinjiang Uygur Autonomous Region Peoples Hospital from January 2016 to December 2017. The clinical symptoms, lumen stenosis degree, and ankle brachial index (ABI) of patients with superficial femoral artery lesions before and after operation were observed to evaluate the improvement of clinical symptoms, lumen patency, and hemodynamics.

Results

Of the 60 patients who had grades 3-6 disease according to the Rutherford classification criteria, 46.67% (28/60) showed significant improvement in clinical symptoms after surgery, and 53.33% (32/60) showed moderate improvement in clinical symptoms Postoperative digital subtraction angiography (DSA) showed a significant decrease in lumen stenosis compared with preoperative value (0.26±0.05 vs 0.9±0.08, t=2.847, P=0.015). Postoperative ABI was significantly higher than preoperative value (0.85±0.11 vs 0.25±0.13, t=1.546, P=0.023).

Conclusion

Turbo Hawk plaque resection can remove the plaque of superficial femoral arteriosclerosis occlusion, open the narrowed or occluded arterial lumen, and improve the clinical symptoms, representing an effective intraluminal volume reduction method.

表1 60例下肢动脉硬化闭塞症患者Rutherford分级及临床表现
表2 术后Rutherfor临床疗效评估标准
表3 60例下肢动脉硬化闭塞症患者旋切术前、术后管腔狭窄程度和ABI比较(±s
图1 股浅动脉狭窄患者术前和术后CTA及造影术结果
1
中华医学会外科学分会血管外科学组. 下肢动脉硬化性闭塞症治疗指南 [J]. 中国实用外科杂志, 2008, 28(11): 923-924.
2
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC Ⅱ) [J]. Eur J Vasc Endovasc Surg, 2007, 33 Suppl 1: S1-75.
3
Laird JR, Yeo KK. The treatment of femoropopliteal instent restenosis: back to the future [J]. J Am Coll Cardiol, 2012, 59(1): 24-25.
4
Yeo KK, Mail U, Laird JR. Outcomes following treatment of femoropopliteal in-stent restenosis: a single-center experience [J]. Catheter Cardiovasc Interv, 2011, 78(4): 604-608.
5
Roberts D, Niazi K, Miller W, et al. DEFINITIVE Ca++ Investigators.Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca++ trial [J]. Catheter Cardiovasc Interv, 2014, 84(2): 236-244.
6
Rutherford RB, Baker DJ, Ernst C, et al. Recommended standards for reports dealing with Lower extremity ischemia: Revised version [J]. J Vasc Surg, 2001, 33(4): 805-808.
7
Lusis AJ. Atherosclerosis [J]. Nature, 2000, 407(6801): 233-241.
8
Criqui MH, Aboyans V. Epidemiology of peripheral artery disease [J]. Circ Res, 2015, 116(9): 1509-1526.
9
Katsanos K, Tepe G, Tsetis D. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting [J]. Cardiovasc Interv Radiol, 2014, 37(3): 592-603.
10
Shammas NW. An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors [J]. Int J Angiol, 2013, 22(1): 1-8.
11
Babaev A, Gokhale R, Zavlunova S, et al. Treatment of Angio-Seal-Related Femoral Artery Occlusion Using Directional Atherectomy—Primary Results and Midterm Follow-Up [J]. Vasc Endovascular Surg, 2016, 50(8): 541-546.
12
Bracale UM, Vitale G, Bajardi G, et al. Use of the directional atherectomy for the treatment of femoro-popliteal lesions in patients with critical lower limb ischemia [J]. Transl Med UniSa, 2016, 15(6): 42-47.
13
Mittleider D, Russell E. Peripheral atherectomy: applications and techniques [J]. Tech Vasc Interv Radiol, 2016, 19(2): 123-135.
14
Stavroulakis K, Bisdas T, Torsello G, et al. Combined directional atherectomy and drug-eluting balloon angioplasty for isolated popliteal artery lesions in patients with peripheral artery disease [J]. J Endovasc Ther, 2015, 22(6): 847-852.
15
Stavroulakis K, Schwindt A, Torsello G, et al. Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for isolated popliteal artery lesions [J]. J Endovasc Ther, 2017, 24(2): 181-188.
16
McKinsey, JF, Zeller T, Rocha-Singh KJ, et al. Lower Extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study [J]. JACC Cardiovasc Interv, 2014, 7(8): 923-933.
[1] 张华, 孙宇, 乡世健, 李樱媚, 王小群. 循环肿瘤细胞预测晚期胃肠癌患者化疗药物敏感性的研究[J]. 中华普通外科学文献(电子版), 2023, 17(06): 422-425.
[2] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[3] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[4] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[5] 汪毅, 许思哲, 任章霞. 胸乳入路腔镜单侧甲状腺叶切除术与开放手术对分化型甲状腺癌患者术后恢复的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 542-545.
[6] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[7] 邰清亮, 施波, 侍新宇, 陈国梁, 陈俊杰, 武冠廷, 王索, 孙金兵, 顾闻, 叶建新, 何宋兵. 腹腔镜次全结肠切除术治疗顽固性慢传输型便秘的疗效分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 478-483.
[8] 徐红莉, 杨钰琳, 薛清, 张茜, 马丽虹, 邱振刚. 体外冲击波治疗非特异性腰痛疗效的系统评价和Meta分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 307-314.
[9] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[10] 高显奎, 赵太云, 陆兴俊, 张洪领, 房修罗, 闫碧春, 王胤, 王永翠, 刘苗苗, 冉若男. 内镜电凝止血与组织胶注射治疗上消化道溃疡伴出血的疗效观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 452-455.
[11] 姜里蛟, 张峰, 周玉萍. 多学科诊疗模式救治老年急性非静脉曲张性上消化道大出血患者的临床观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 520-524.
[12] 张景旭, 李德舫, 由上可, 张玉田. 贝伐珠单抗与安罗替尼联合奥沙利铂治疗晚期直肠癌的临床疗效[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 289-293.
[13] 杨镠, 秦岚群, 耿茜, 李栋庆, 戚春建, 蒋华. 可溶性免疫检查点对胃癌患者免疫治疗疗效和预后的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 305-311.
[14] 盛静, 梅勇, 夏佩, 王晓林. 乌苯美司联合伊立替康二线治疗晚期胃癌的临床研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 317-321.
[15] 李莹倩, 李华山. 基于真实世界的完全性直肠脱垂治疗方式评价[J]. 中华临床医师杂志(电子版), 2023, 17(06): 700-705.
阅读次数
全文


摘要